GlassScriptPhysician profile
Wendi J Lundquist
NPI 1801847546
$6,596.59
in general payments reported to CMS, 2019-2025
36 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $398 · 2021: $1,562 · 2022: $1,253 · 2023: $1,096 · 2024: $1,254 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873 · Travel and Lodging: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,873.40 |
| Travel and Lodging | $586.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,002.07 | 2021-2022 | |
| Abbvie INC. | $868.92 | 2021-2025 | |
| Boston Scientific Corporation | $868.72 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Allergan, INC. | $561.16 | 2019-2022 | |
| Relievant Medsystems, INC. | $406.75 | 2019-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $316.17 | 2019-2024 | Belbuca, Xtampza |
| Nevro Corp. | $256.54 | 2019-2022 | |
| Saluda Medical Americas, INC. | $254.14 | 2024-2025 | Evoke |
| Merz North America, INC. | $231.96 | 2019-2023 | Xeomin |
| Spr Therapeutics, INC | $215.94 | 2021-2024 | Sprint Pns System |
| Radius Health, INC. | $173.57 | 2021 | |
| Vertiflex, INC. | $151.94 | 2019 | |
| Scilex Pharmaceuticals INC. | $143.78 | 2019-2023 | Ztlido |
| Merz Pharmaceuticals, LLC | $133.06 | 2021-2024 | Xeomin |
| Amgen INC. | $104.43 | 2021-2023 | Evenity, Prolia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $81.72 | 2020-2021 | |
| Fidia Pharma USA INC. | $78.05 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.22 | 2022 | |
| Pfizer INC. | $57.81 | 2023-2024 | |
| Vertos Medical, INC. | $54.62 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $52.02 | 2019-2021 | |
| Nalu Medical, INC. | $51.79 | 2021-2024 | Nalu Neurostimulation System |
| Teva Pharmaceuticals USA, INC. | $48.91 | 2021 | |
| Medtronic USA, INC. | $48.79 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $48.52 | 2019 | |
| Sientra, INC. | $47.82 | 2019 | |
| Currax Pharmaceuticals LLC | $46.72 | 2020-2023 | Contrave, Onzetra Xsail |
| Pacira Pharmaceuticals Incorporated | $42.76 | 2019 | |
| Abbott Laboratories | $35.78 | 2021-2024 | Proclaim |
| Horizon Therapeutics Plc | $30.01 | 2019-2021 | |
| Depuy Synthes Sales INC. | $29.46 | 2019-2024 | Orthovisc |
| Alfasigma USA, INC. | $25.51 | 2021 | |
| Lilly USA, LLC | $19.77 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.26 | 2021 | |
| Theragen, INC. | $13.21 | 2022 | |
| Grt US Holding, INC. | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendi Lundquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.